-
3
-
-
1442306232
-
Drug-induced prolongation of the QT interval
-
DOI 10.1056/NEJMra032426
-
DM Roden 2004 N Engl J Med 350 1013 10.1056/NEJMra032426 1:CAS:528:DC%2BD2cXhvFGjs7Y%3D (Pubitemid 38269278)
-
(2004)
New England Journal of Medicine
, vol.350
, Issue.10
, pp. 1013-1022
-
-
Roden, D.M.1
-
5
-
-
0344492207
-
Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: Evidence for a provisional safety margin in drug development
-
DOI 10.1016/S0008-6363(02)00846-5
-
WS Redfern L Carlsson AS Davis WG Lynch I MacKenzie S Palethorpe PK Siegl I Strang AT Sullivan R Wallis AJ Camm TG Hammond 2003 Cardiovasc Res 58 32 10.1016/S0008-6363(02)00846-5 1:CAS:528:DC%2BD3sXit12gsb8%3D (Pubitemid 36351620)
-
(2003)
Cardiovascular Research
, vol.58
, Issue.1
, pp. 32-45
-
-
Redfern, W.S.1
Carlsson, L.2
Davis, A.S.3
Lynch, W.G.4
MacKenzie, I.5
Palethorpe, S.6
Siegl, P.K.S.7
Strang, I.8
Sullivan, A.T.9
Wallis, R.10
Camm, A.J.11
Hammond, T.G.12
-
9
-
-
0035046155
-
The positive inotropic and chronotropic effects of evodiamine and rutaecarpine, indoloquinazoline alkaloids isolated from the fruits of Evodia rutaecarpa, on the guinea-pig isolated right atria: Possible involvement of vanilloid receptors
-
DOI 10.1055/s-2001-12008
-
Y Kobayashi K Hoshikuma Y Nakano Y Yokoo T Kamiya 2001 Planta Med 67 244 10.1055/s-2001-12008 1:CAS:528:DC%2BD3MXjtVehsbg%3D (Pubitemid 32304195)
-
(2001)
Planta Medica
, vol.67
, Issue.3
, pp. 244-248
-
-
Kobayashi, Y.1
Hoshikuma, K.2
Nakano, Y.3
Yokoo, Y.4
Kamiya, T.5
-
11
-
-
33750998518
-
Common pharmacophores for uncharged human ether-a-go-go-related gene (hERG) blockers
-
DOI 10.1021/jm060500o
-
AM Aronov 2006 J Med Chem 49 6917 10.1021/jm060500o 1:CAS:528: DC%2BD28XhtVyntbrJ (Pubitemid 44749757)
-
(2006)
Journal of Medicinal Chemistry
, vol.49
, Issue.23
, pp. 6917-6921
-
-
Aronov, A.M.1
-
12
-
-
1842686775
-
+ channel blockers
-
DOI 10.1016/j.bmc.2004.02.003, PII S096808960400104X
-
AM Aronov BB Goldman 2004 Bioorg Med Chem 12 2307 10.1016/j.bmc.2004.02. 003 1:CAS:528:DC%2BD2cXjtVKqu7g%3D (Pubitemid 38471715)
-
(2004)
Bioorganic and Medicinal Chemistry
, vol.12
, Issue.9
, pp. 2307-2315
-
-
Aronov, A.M.1
Goldman, B.B.2
-
13
-
-
33746275630
-
In silico classification of hERG channel blockers: A knowledge-based strategy
-
DOI 10.1002/cmdc.200500099
-
E Dubus I Ijjaali F Petitet A Michel 2006 ChemMedChem 1 622 10.1002/cmdc.200500099 1:CAS:528:DC%2BD2sXjsVCmtr4%3D (Pubitemid 44105788)
-
(2006)
ChemMedChem
, vol.1
, Issue.6
, pp. 622-630
-
-
Dubus, E.1
Ijjaali, I.2
Petitet, F.3
Michel, A.4
-
15
-
-
13944268698
-
Greater than the sum of its parts: Combining models for useful ADMET prediction
-
DOI 10.1021/jm049254b
-
SE O'Brien MJ de Groot 2005 J Med Chem 48 1287 10.1021/jm049254b (Pubitemid 40270476)
-
(2005)
Journal of Medicinal Chemistry
, vol.48
, Issue.4
, pp. 1287-1291
-
-
O'Brien, S.E.1
De Groot, M.J.2
-
16
-
-
0038743107
-
Characterization of HERG potassium channel inhibition using CoMSiA 3D QSAR and homology modeling approaches
-
DOI 10.1016/S0960-894X(03)00196-3
-
RA Pearlstein RJ Vaz J Kang XL Chen M Preobrazhenskaya AE Shchekotikhin AM Korolev LN Lysenkova OV Miroshnikova J Hendrix D Rampe 2003 Bioorg Med Chem Lett 13 1829 10.1016/S0960-894X(03)00196-3 1:CAS:528:DC%2BD3sXjt1Kjtrk%3D (Pubitemid 36561175)
-
(2003)
Bioorganic and Medicinal Chemistry Letters
, vol.13
, Issue.10
, pp. 1829-1835
-
-
Pearlstein, R.A.1
Vaz, R.J.2
Kang, J.3
Chen, X.-L.4
Preobrazhenskaya, M.5
Shchekotikhin, A.E.6
Korolev, A.M.7
Lysenkova, L.N.8
Miroshnikova, O.V.9
Hendrix, J.10
Rampe, D.11
-
18
-
-
0036904104
-
A virtual screening method for prediction of the hERG potassium channel liability of compound libraries
-
DOI 10.1002/1439-7633(20020503)3:5<455::AID-CBIC455>3.0.CO;2-L
-
O Roche G Trube J Zuegge P Pflimlin A Alanine G Schneider 2002 Chembiochem 3 455 10.1002/1439-7633(20020503)3:5<455::AID-CBIC455>3.0. CO;2-L 1:CAS:528:DC%2BD38XjslWit74%3D (Pubitemid 36002290)
-
(2002)
ChemBioChem
, vol.3
, Issue.5
, pp. 455-459
-
-
Roche, O.1
Trube, G.2
Zuegge, J.3
Pflimlin, P.4
Alanine, A.5
Schneider, G.6
-
19
-
-
14644412444
-
Predicting drug-hERG channel interactions that cause acquired long QT syndrome
-
DOI 10.1016/j.tips.2005.01.003
-
MC Sanguinetti JS Mitcheson 2005 Trends Pharmacol Sci 26 119 10.1016/j.tips.2005.01.003 1:CAS:528:DC%2BD2MXitVeisLg%3D (Pubitemid 40313590)
-
(2005)
Trends in Pharmacological Sciences
, vol.26
, Issue.3
, pp. 119-124
-
-
Sanguinetti, M.C.1
Mitcheson, J.S.2
-
21
-
-
1542327276
-
Predicting undesirable drug interactions with promiscuous proteins in silico
-
DOI 10.1016/S1359-6446(03)03008-3, PII S1359644603030083
-
S Ekins 2004 Drug Discov Today 9 276 10.1016/S1359-6446(03)03008-3 1:CAS:528:DC%2BD2cXhslelsLc%3D (Pubitemid 38328514)
-
(2004)
Drug Discovery Today
, vol.9
, Issue.6
, pp. 276-285
-
-
Ekins, S.1
-
22
-
-
13844254976
-
Predictive in silico modeling for hERG channel blockers
-
DOI 10.1016/S1359-6446(04)03278-7, PII S1359644604032787
-
AM Aronov 2005 Drug Discov Today 10 149 10.1016/S1359-6446(04)03278-7 1:CAS:528:DC%2BD2MXhsFarsbY%3D (Pubitemid 40247813)
-
(2005)
Drug Discovery Today
, vol.10
, Issue.2
, pp. 149-155
-
-
Aronov, A.M.1
-
23
-
-
26944503021
-
Using extended-connectivity fingerprints with Laplacian-modified Bayesian analysis in high-throughput screening follow-up
-
DOI 10.1177/1087057105281365
-
D Rogers RD Brown M Hahn 2005 J Biomol Screen 10 682 10.1177/ 1087057105281365 1:CAS:528:DC%2BD2MXhtF2qs77L (Pubitemid 41476802)
-
(2005)
Journal of Biomolecular Screening
, vol.10
, Issue.7
, pp. 682-686
-
-
Rogers, D.1
Brown, R.D.2
Hahn, M.3
-
27
-
-
33745821727
-
Can we estimate the accuracy of ADME-Tox predictions?
-
DOI 10.1016/j.drudis.2006.06.013, PII S1359644606002303
-
IV Tetko P Bruneau HW Mewes DC Rohrer GI Poda 2006 Drug Discov Today 11 700 10.1016/j.drudis.2006.06.013 1:CAS:528:DC%2BD28XntFSgtrw%3D (Pubitemid 44038632)
-
(2006)
Drug Discovery Today
, vol.11
, Issue.15-16
, pp. 700-707
-
-
Tetko, I.V.1
Bruneau, P.2
Mewes, H.-W.3
Rohrer, D.C.4
Poda, G.I.5
-
32
-
-
54249125512
-
-
10.1021/ci800151m 1:CAS:528:DC%2BD1cXhtVaru7bF
-
IV Tetko I Sushko AK Pandey H Zhu A Tropsha E Papa T Oberg R Todeschini D Fourches A Varnek 2008 J Chem Inf Model 48 1733 10.1021/ci800151m 1:CAS:528:DC%2BD1cXhtVaru7bF
-
(2008)
J Chem Inf Model
, vol.48
, pp. 1733
-
-
Tetko, I.V.1
Sushko, I.2
Pandey, A.K.3
Zhu, H.4
Tropsha, A.5
Papa, E.6
Oberg, T.7
Todeschini, R.8
Fourches, D.9
Varnek, A.10
-
33
-
-
33644524405
-
Are hERG channel inhibition and QT interval prolongation all there is in drug-induced torsadogenesis? A review of emerging trends
-
DOI 10.1016/j.vascn.2005.07.003, PII S1056871905000936
-
P Hoffmann B Warner 2006 J Pharmacol Toxicol Methods 53 87 10.1016/j.vascn.2005.07.003 1:CAS:528:DC%2BD28Xhslymsbg%3D (Pubitemid 43295657)
-
(2006)
Journal of Pharmacological and Toxicological Methods
, vol.53
, Issue.2
, pp. 87-105
-
-
Hoffmann, P.1
Warner, B.2
-
34
-
-
10744222463
-
Drug binding to aromatic residues in the HERG channel pore cavity as possible explanation for acquired Long QT syndrome by antiparkinsonian drug budipine
-
DOI 10.1007/s00210-003-0805-5
-
EP Scholz E Zitron C Kiesecker S Lueck S Kathofer D Thomas S Weretka S Peth VA Kreye W Schoels HA Katus J Kiehn CA Karle 2003 Naunyn Schmiedebergs Arch Pharmacol 368 404 10.1007/s00210-003-0805-5 1:CAS:528:DC%2BD3sXovFOitrs%3D (Pubitemid 37491500)
-
(2003)
Naunyn-Schmiedeberg's Archives of Pharmacology
, vol.368
, Issue.5
, pp. 404-414
-
-
Scholz, E.P.1
Zitron, E.2
Kiesecker, C.3
Lueck, S.4
Kathofer, S.5
Thomas, D.6
Weretka, S.7
Peth, S.8
Kreye, V.A.W.9
Schoels, W.10
Katus, H.A.11
Kiehn, J.12
Karle, C.A.13
-
35
-
-
0038407463
-
Voltage-dependent profile of human ether-a-go-go-related gene channel block is influenced by a single residue in the S6 transmembrane domain
-
DOI 10.1124/mol.63.5.1051
-
JA Sanchez-Chapula T Ferrer RA Navarro-Polanco MC Sanguinetti 2003 Mol Pharmacol 63 1051 10.1124/mol.63.5.1051 1:CAS:528:DC%2BD3sXjt12lu70%3D (Pubitemid 36529923)
-
(2003)
Molecular Pharmacology
, vol.63
, Issue.5
, pp. 1051-1058
-
-
Sanchez-Chapula, J.A.1
Ferrer, T.2
Navarro-Polanco, R.A.3
Sanguinetti, M.C.4
-
37
-
-
76449117131
-
Designing drugs and crop protectants: Processes, problems and solutions
-
Buyck C, Tollenaere J, Engels M, De Clerck F (2002) Designing drugs and crop protectants: processes, problems and solutions. EuroQSAR 2002
-
(2002)
EuroQSAR
-
-
Buyck, C.1
Tollenaere, J.2
Engels, M.3
De Clerck, F.4
-
39
-
-
0345276789
-
+-Channel Modulation, a New Principle of Inotropic Intervention: Effects on Hemodynamic and Myocardial Energetics in the Immature Rabbit Heart
-
DOI 10.1203/01.PDR.0000091286.21994.E5
-
H Schiffmann V Rizouli F Luers F Hackmann D Hoebel A Pfahlberg G Hellige 2003 Pediatr Res 54 875 10.1203/01.PDR.0000091286.21994.E5 1:CAS:528: DC%2BD3sXptV2jtb4%3D (Pubitemid 37456553)
-
(2003)
Pediatric Research
, vol.54
, Issue.6
, pp. 875-884
-
-
Schiffmann, H.1
Rizouli, V.2
Luers, F.3
Hackmann, F.4
Hoebel, D.5
Pfahlberg, A.6
Hellige, G.7
-
41
-
-
0036682190
-
Cardiovascular characterization of [1,4]thiazino[3,4-c][1,2,4]oxadiazol- 1-one derivatives: Selective myocardial calcium channel modulators
-
DOI 10.1021/jm020815d
-
R Budriesi B Cosimelli P Ioan CZ Lanza D Spinelli A Chiarini 2002 J Med Chem 45 3475 10.1021/jm020815d 1:CAS:528:DC%2BD38XkvVygtbo%3D (Pubitemid 34824035)
-
(2002)
Journal of Medicinal Chemistry
, vol.45
, Issue.16
, pp. 3475-3481
-
-
Budriesi, R.1
Cosimelli, B.2
Ioan, P.3
Lanza, C.Z.4
Spinelli, D.5
Chiarini, A.6
-
44
-
-
0026348266
-
-
1:CAS:528:DyaK3MXmslSnsr4%3D
-
T Shirayama D Inoue M Inoue T Tatsumi Y Yamahara J Asayama H Katsume M Nakagawa 1991 J Pharmacol Exp Ther 259 884 1:CAS:528:DyaK3MXmslSnsr4%3D
-
(1991)
J Pharmacol Exp Ther
, vol.259
, pp. 884
-
-
Shirayama, T.1
Inoue, D.2
Inoue, M.3
Tatsumi, T.4
Yamahara, Y.5
Asayama, J.6
Katsume, H.7
Nakagawa, M.8
|